Pancreatic Cancer Research

ResearcherChiba Cancer Center Research InstituteNo recent work listed

Mizuyo Nakamura

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5033947004. Sources: OpenAlex.

Their work

Papers
6 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper

Papers 6

  1. Impact of RUNX2 gene silencing on the gemcitabine sensitivity of p53‑mutated pancreatic cancer MiaPaCa‑2 spheres. First author DOI 10.3892/or.2018.6344↗
  2. Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 … First author DOI 10.1371/journal.pone.0179884↗
  3. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death. Co-author DOI 10.1038/oncsis.2016.40↗
  4. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TA… First author DOI 10.18632/oncotarget.12433↗
  5. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. First author DOI 10.1038/cddis.2015.242↗
  6. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. First author DOI 10.1038/cddiscovery.2015.10↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshinori Ozaki · 6 shared papers, 2015–2018 · strength 0.38
  2. Osamu Shimozato · 6 shared papers, 2015–2018 · strength 0.38
  3. Meijie Sang · 5 shared papers, 2015–2018 · strength 0.33
  4. Takehiro Ogata · 3 shared papers, 2016–2018 · strength 0.22
  5. Meixiang Sang · 3 shared papers, 2015–2017 · strength 0.18
  6. Hirokazu Sugimoto · 3 shared papers, 2015–2016 · strength 0.15
  7. Hiroki Nagase · 2 shared papers, 2015 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.